ReviewActa haematologica2025

Belantamab Mafodotin in Relapsed/Refractory AL Amyloidosis: Real-World Multi-Center Experience and Review of the Literature.

Eyal Lebel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.